Sight-saving glue that repairs serious eye problems without surgery is developed by scientists

Sight-saving glue that repairs serious eye problems without surgery is developed by scientists

A GLUE which repairs serious eye injuries without surgery has been developed by scientists.
The adhesive gel has light-sensitive chemicals that seal cuts or ulcers on the cornea.
Getty – Contributor Scientists have developed a glue which could put an end to thousands of eye surgeries
Experts hope it could put an end to corneal transplants, about 4,000 of which are carried out each year in the UK.
There is a severe shortage of the donor tissue for these ops worldwide.
The GelCORE glue fills gaps and even fuels tissue growth. It was developed at Harvard Medical School in Boston, US.
The non invasive technique could replace operations for any injury to the cornea. More than 1.5 million new cases of corneal blindness are reported every year.
An eye infection or trauma on the surface of the eye can cause scarring – leading to blurring or complete vision loss.
The current standard treatments for filling in cuts, thinning areas or holes – called corneal defects – include synthetic glues as well as surgery.
But these are rough, toxic, difficult to handle and can lead to significant vision loss due to the material’s opacity and poor integration with corneal tissues.
Graphic WarningTHE ‘CURSED’ CHILD A MUM WON’T LOVE Heartbreaking photos show the premature baby whose mum won’t hold or feed her LIFE-SAVING OP Baby girl born with her parasitic twin’s HEAD attached to her tummy undergoes surgery to remove it SEX CLUES This is how much sex you SHOULD be having… according to your age DO YOU KNOW THE SIGNS? One in five bowel cancer patients suffer ‘red flag’ signs a YEAR before diagnosis BRAIN DAMAGE DANGER Doll shows the horrifying reality of what really happens to a baby’s brain when they are shaken Exclusive’you really are never too young’ Fit and healthy mum battles bowel cancer at just 35 – and urges YOU to check for the warning signs
Corneal transplants also carry risks of post-transplant complications – including infection or rejection.
The US team say GelCORE – described in Science Advances – addresses this unmet clinical need.
Human trials will start in about a year.
When I spotted bizarre white dot in my baby boy’s eye, I knew it was deadly cancer



Please enter your comment!
Please enter your name here